Equity Overview
Price & Market Data
Price: $1.99
Daily Change: $0.00 / 0.00%
Daily Range: $0 - $0
Market Cap: $23,036,240
Daily Volume: 0
Performance Metrics
1 Week: 12.43%
1 Month: 22.09%
3 Months: -50.75%
6 Months: -50.75%
1 Year: -50.75%
YTD: -9.55%
Company Details
Employees: 2
Sector: Health technology
Industry: Biotechnology
Country:
Details
Apimeds Pharmaceuticals US, Inc. operates as a clinical stage biopharmaceutical company in the United States. It researches, develops, manufactures, commercializes, and sells Apitox, a purified, pharmaceutical grade venom of the Apis mellifera, or honeybee for the treatment of inflammation and pain management symptoms associated with osteoarthritis and multiple sclerosis. The company was incorporated in 2020 and is based in Hopewell, New Jersey.